Search

Your search keyword '"Fietkau R"' showing total 1,474 results

Search Constraints

Start Over You searched for: Author "Fietkau R" Remove constraint Author: "Fietkau R"
1,474 results on '"Fietkau R"'

Search Results

2. Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

3. F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial

4. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations: An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO)

7. R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

8. Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

10. OA17.03 Real-World Outcomes with Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC (PACIFIC-R)

15. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis

16. PO-2244 The effect of hyperthermia and radiation therapy sequence on the immune phenotype of breast cancer

19. OC-0830 Accelerated partial breast irradiation: 10-year results of a randomized GEC-ESTRO phase III trial

20. Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

22. Neoadjuvantes Behandlungskonzept

23. Multimodale Therapien zum Blasenerhalt bei High-grade-Blasentumoren

30. 58O Real-world overall survival (OS) with durvalumab (D) after chemoradiotherapy (CRT) in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): Interim analysis from the PACIFIC-R study

40. 1247P Radiotherapy (RT) patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients (pts) with Stage III unresectable non-small cell lung cancer (UR-NSCLC) treated with durvalumab (D) after chemoradiotherapy (CRT)

41. TIGER PRO-Active study – investigating daily activity, sleep and neurocognitive functioning in glioblastoma patients applying TTFields therapy in Germany in routine clinical care

42. First results of the TIGER study – treatment decision and quality of life of glioblastoma patients during TTFields therapy in routine clinical care

43. The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma

44. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations

47. OC-0833 Total neoadjuvant therapy for Organ Preservation in Rectal Cancer: The CAO/ARO/AIO-16 phase II trial

Catalog

Books, media, physical & digital resources